eagle-i Charles Drew University of Medicine and ScienceCharles Drew University of Medicine and Science
See it in Search
This page is a preview of the following resource. Continue onto eagle-i search using the button on the right to see the full record.

The Effects of Short Term Administration of a Glutathione Precursor (FT061452),on Serum and Intracellular Glutathione Levels

eagle-i ID

http://cdrewu.eagle-i.net/i/00000136-1d05-d6ba-1a88-e81c80000000

Resource Type

  1. Parallel group study

Properties

  1. Intervention
    Placebo
  2. Intervention
    Active Comparator: N-Acetyl Cysteine (NAC), 600mg/1200mg po x1
  3. Intervention
    Experimental: Proimmune 200, 3000mg/6000mg
  4. Additional Topic(s)
    Vascular function
  5. Resource Description
    "Glutathione is a powerful protective substance found within every cell in the body. It has been shown that glutathione levels go down as a person gets older, which makes a person more likely to get heart disease, high blood sugar problems and different kind of cancers. N-Acetyl Cysteine is used as a dietary supplement. It has been reported to increase glutathione levels in the body. The diet supplement called ProImmune is also changed by the body into glutathione. Therefore, the purpose of this study is to find out the effect of ProImmune in healthy people. This study will also help to prove whether or not the ProImmune is able to improve the blood levels of glutathione in healthy people."
  6. PI
    Tareen, Naureen, M.D.
  7. Performed by
    Clinical and Translational Research Center
 
RDFRDF
 
Provenance Metadata About This Resource Record
  1. workflow state
    Published
  2. contributor
    efleming (Erik Fleming)
  3. created
    2012-03-16T14:47:15.584-05:00
  4. creator
    efleming (Erik Fleming)
  5. modified
    2012-04-05T14:05:27.454-05:00

Copyright © 2016 by the President and Fellows of Harvard College
The eagle-i Consortium is supported by NIH Grant #5U24RR029825-02 / Copyright 2016